In a recent study [63] of a cohort of 75 tumours from patients with a mucosal melanoma, NF1 and RAS mutations were identified in 18.3 and 16.9% samples, respectively, whereas 8.4 and 7% of tumour samples harboured BRAF and KIT mutations [63]. Here, BRAF is linked to neoplasm.